The Anti-Proliferative Effect of Plasma from Rats with Acute Fulminant Hepatic Failure

References

• Hoofnagle J H, Carithers R L, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240–52
   PubMed Web of Science ®Google Scholar
• Nolan J P. Intestinal endotoxin as mediators of hepatic injury: an idea whose time has come again. Hepatology 1989; 10: 887–91
   PubMed Web of Science ®Google Scholar
• Triger D R. Endotoxin in liver disease: time for re‐appraisal. J Hepatol 1991; 12: 136–8
   PubMed Web of Science ®Google Scholar
• Bernuau J, Rueff B, Benhamou J P. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986; 6: 97–106
   PubMed Web of Science ®Google Scholar
• Konstantin P, Chang J, Otto V, Brunner G. Artificial liver. Artif Organs 1991; 16: 235–42
   Google Scholar
• Chenard‐Neu M P, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure: a multicenter European study. Hepatology 1996; 23: 1119–27
   PubMed Web of Science ®Google Scholar
• Tomiya T, Fujiwara K. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels. Hepatology 1996; 23: 253–7
   PubMedGoogle Scholar
• Gove C D, Hughes R D. Liver regeneration in relation to acute liver failure. Gut 1991; 32s: 92–6
   Google Scholar
• Yamada H, Toda G, Yoshiba M, Williams R. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant hepatic failure. Hepatology 1994; 19: 1133–40
   PubMedGoogle Scholar
• Hughes R D, Yamada H, Gove C D, Williams R. Inhibition of hepatic DNA synthesis in fulminant hepatic failure. Dig Dis Sci 1991; 36: 816–9
   PubMed Web of Science ®Google Scholar
• Ryan C J, Aslam M, Courtney J M. Experimental procedures for the assessment of artificial liver support. Acute liver failure. Proceedings of the 11th BSG/ SK & F International Workshop; 1991, R Williams, R D Hughes. Milter Press Ltd, Dorset, LondonUK 1991; 81–96
   Google Scholar
• Golding M, Sarraf C E, Lalani N, Anilkumar T V, Edwards R J, Nagy P, et al. Oval cell differentiation into hepatocytes in the acetylaminofiuorene‐treated regenerating rat liver. Hepatology 1995; 22: 1243–53
   PubMed Web of Science ®Google Scholar
• Anilkumar T V, Golding M, Edwards R J, Lalani El‐N, Sarraf C E, Alison M R. The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules. Carcinogenesis 1995; 16: 845–53
   PubMed Web of Science ®Google Scholar
• Senior P V, Critchley D R, Beck F, Walker R A, Varley J M. The localisation of laminin mRNA and protein in the postimplanta‐tion embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study. Development 1988; 104: 431–46
   PubMed Web of Science ®Google Scholar
• Keppler D, Decker K. Experimental hepatitis induced by D‐galactosamine. Exp Mol Pathol 1968; 9: 279–90
   PubMed Web of Science ®Google Scholar
• Sarraf C E, Lalani El‐N, Golding M, Anilkumar T V, Poulsom R, Alison M R. Cell behavior in the acetylaminofiuorene‐treated regenerating rat liver: light and electron microscopic observations. Am J Pathol 1994; 145: 1114–26
   PubMedGoogle Scholar
• Alison M R, Golding M, Sarraf C E, Edwards R J, Lalani El‐N. Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology 1996; 110: 1182–90
   PubMed Web of Science ®Google Scholar
• Ryan C J, Courtney J M, Blumgart L H. Haemoperfusion and DNA synthesis in the rat liver. I. I. The effect of haemoperfusion on DNA synthesis in the rat liver undergoing compensatory hyperplasia after partial hepatectomy. Artif Organs 1982; 6: 182–9
   PubMed Web of Science ®Google Scholar
• Ryan C J, Pusey C D, Aslam M, Gaylor J D S, Maini R, Courtney J M. Repeated membrane plasma separation with on‐line sorbent treatment of plasma in the conscious rat. Artif Organs 1986; 10: 135–14
   PubMedGoogle Scholar
• Cohen J, Aslam M, Pusey C D, Ryan C J. Protection from endotoxaemia: a rat model of plasmapheresis and specific absorption with polymysin B. Br J Infect Dis 1987; 155: 690–5
   Google Scholar
• Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, et al. Clinical significance of hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989; 9: 875–81
   PubMedGoogle Scholar
• Schanne F A, Pfau R G, Farber J L. Galactosamine‐induced cell death in primary cultures of rat hepatocytes. Am J Pathol 1980; 100: 25–38
   PubMedGoogle Scholar
• Morikawa A, Sugiyama T, Kato Y, Koide N, Jiang G Z, Takashashi K, et al. Apoptotic cell death in the response of D‐galactosamine‐sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect Immun 1996; 64: 734–8
   PubMed Web of Science ®Google Scholar
• Lemire J M, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D‐galactosamine. Am J Pathol 1991; 139: 535–52
   PubMed Web of Science ®Google Scholar
• Dabeva M D, Shafritz D A. Activation, proliferation and differentiation of progenitor cells into hepatocytes in the D‐galactosa‐mine model of liver regeneration. Am J Pathol 1993; 143: 1606–20
   PubMed Web of Science ®Google Scholar
• Dixit V, Chang T M. Brain edema and the blood brain barrier in galactosamine‐induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. ASAIO Trans 1990; 36: 21–7
   PubMedGoogle Scholar
• Grisham J W. Hepatocyte proliferation in normal rats after multiple exchange transfusions with blood from partially hepatectomised rats. Cell Tissue Kinet 1969; 2: 277–82
   Google Scholar
• Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, Kaiho T, et al. Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy. Am J Gastroenterol 1996; 91: 116–21
   PubMedGoogle Scholar
• Ryan C J, Aslam M, Courtney J M. Transferance of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange. Biomater Artif Cells Artif Organs 1990; 18: 477–82
   PubMed Web of Science ®Google Scholar
• Alison M R, Poulsom R, Jeffrey R, Anilkumar T V, Jagoe R, Sarraf C E. Expression of hepatocyte growth factor mRNA during oval cell activation in the rat liver. J Pathol 1993; 171: 291–9
   PubMedGoogle Scholar
• Hu Z, Evarts R P, Fujio K, Marsden E R, Thorgeirsson S S. Expression of hepatocyte growth factor and c‐met genes during hepatic differentiation and liver development in the rat. Am J Pathol 1993; 142: 1823–30
   PubMedGoogle Scholar